Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Circulating tumor DNA can help detect treatment options for ovarian cancer subtype

According to a new research, circulating tumor DNA can be used detect treatment options for ovarian cancer patients who don't benefit from chemotherapy.

6 May 2019

Researchers identify 34 genes associated with increased risk of ovarian cancer

A team of researchers at UCLA's Jonsson Comprehensive Cancer, Cedars-Sinai Cancer and Dana-Farber Cancer Institute have newly identified 34 genes that are associated with an increased risk for developing the earliest stages of ovarian cancer.

1 May 2019

Delving into tumor's cellular lineage may offer clues for customized therapies

To explain a person's actions in the present, it sometimes helps to understand their past, including where they come from and how they were raised.

25 Apr 2019

Johns Hopkins researchers uncover role of neurotransmitter in the spread of aggressive cancers

Using human cancer cells, tumor and blood samples from cancer patients, researchers at Johns Hopkins Medicine have uncovered the role of a neurotransmitter in the spread of aggressive cancers. Neurotransmitters are chemical "messengers" that transmit impulses from neurons to other target cells.

25 Apr 2019

Novel fluorescence imaging system helps surgeons remove small ovarian tumors

Ovarian cancer is usually diagnosed only after it has reached an advanced stage, with many tumors spread throughout the abdomen.

24 Apr 2019

Precision-guided anticancer nanoparticles help enhance treatment of peritoneal tumors

Research carried out at the University of Tartu Faculty of Medicine used nanoparticles for the development of new imaging and treatment methods for peritoneal cancers. Tests showed that precision-guided anticancer nanoparticles have improved efficacy and reduced side effects.

22 Apr 2019

Molecular target UNC45A is essential for cancer cell proliferation and tumor growth

Identifying a protein that plays a key role in cancer cell growth is a first step toward the development of a targeted cancer therapy. It is especially promising when this protein is dispensable for the growth of normal cells.

19 Apr 2019

Study describes vulnerability shared by large subset of cancer cell lines

Cancer cells adapt to potentially fatal mutations and other molecular malfunctions by adjusting one or more other genes' activity, in the process becoming dependent on those genes for their survival and growth.

12 Apr 2019

Ludwig scientists to share advances in cancer research at AACR Annual Meeting 2019

Ludwig Cancer Research released today the full breadth of findings to be presented by Ludwig researchers at this year's American Association for Cancer Research (AACR) Annual Meeting in Atlanta, Ga., March 29 - April 3, 2019.

22 Mar 2019

New class of drugs could help treat patients diagnosed with ovarian cancer

A team of researchers across The University of Manchester have shown that a new class of drugs are able to stop ovarian cancer cells growing.

19 Mar 2019

New proteomics-based test could aid in early detection of ovarian cancer

Fewer than half of ovarian cancer patients survive until five years after diagnosis. According to the American Cancer Society, this is because only about one-fifth of ovarian cancer cases are detected early, when the chances of successful treatment and recovery are highest.

15 Mar 2019

Fertility problems may raise risk of cancer in women

New research shows that women who have fertility problems are 18 percent more likely to develop ovarian and endometrial or womb cancers in later life.

13 Mar 2019

Precision cancer drugs spark powerful immune response and boost effects of immunotherapy

Precision cancer drugs called PARP inhibitors have a previously unknown ability to boost the immune system, and could help many more patients benefit from immunotherapy, a new study reveals.

11 Mar 2019

New imaging technology could help find tiny tumors

Many types of cancer could be more easily treated if they were detected at an earlier stage. MIT researchers have now developed an imaging system, named "DOLPHIN," which could enable them to find tiny tumors, as small as a couple of hundred cells, deep within the body.

7 Mar 2019

Scientists identify how cells make choice between various mechanisms to repair DNA

When DNA in the cell nucleus gets damaged, our cells can resort to a variety of repair mechanisms. A recent study published in 'Nature Cell Biology', to which scientists from Helmholtz Zentrum Muenchen made major contributions, elucidates the molecular basis by which a cell makes the choice between these repair mechanisms.

28 Feb 2019

Porvair Sciences to improve the diagnosis and treatment of ovarian cancer

Porvair Sciences reports on its involvement in a new £2.6 million project led by Swansea University (UK) that aims to dramatically improve the diagnosis and treatment of ovarian cancer.

From Chromatrap® - Porvair Sciences Ltd 27 Feb 2019

Miniature tumor organoids could help guide treatment decisions for people with rare cancers

UCLA scientists have developed a new method to quickly screen hundreds of drugs in order to identify treatments that can target specific tumors.

26 Feb 2019

'Chromosome scanner' that protects against cancer identified

In a new study, researchers from the University of Copenhagen have identified one of the main mechanisms behind the repair of serious damage to the human DNA. A 'scanner' inside the cells decides whether or not so-called flawless DNA repair, which protects against cancer, is launched.

26 Feb 2019

New analysis highlights increasing focus of early-stage clinical trials on rare cancers

The proportion of early-stage drug trials tackling the biggest cancer killers has declined sharply since the early 1990s as less common tumor types receive increasing attention, according to new research to be presented during the International Congress on Targeted Anticancer Therapies 2019, taking place from today to 27 February in Paris, France.

25 Feb 2019

Breast cancer study: Family-history-based models perform better than non-family-history based models

A team of researchers led by Columbia University Mailman School of Public Health Professor Mary Beth Terry, PhD, evaluated four commonly used breast cancer prediction models and found that family-history-based models perform better than non-family-history based models, even for women at average or below-average risk of breast cancer.

22 Feb 2019

Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Circulating tumor DNA can help detect treatment options for ovarian cancer subtype

Researchers identify 34 genes associated with increased risk of ovarian cancer

Delving into tumor's cellular lineage may offer clues for customized therapies

Johns Hopkins researchers uncover role of neurotransmitter in the spread of aggressive cancers

Novel fluorescence imaging system helps surgeons remove small ovarian tumors

Precision-guided anticancer nanoparticles help enhance treatment of peritoneal tumors

Molecular target UNC45A is essential for cancer cell proliferation and tumor growth

Study describes vulnerability shared by large subset of cancer cell lines

Ludwig scientists to share advances in cancer research at AACR Annual Meeting 2019

New class of drugs could help treat patients diagnosed with ovarian cancer

New proteomics-based test could aid in early detection of ovarian cancer

Fertility problems may raise risk of cancer in women

Precision cancer drugs spark powerful immune response and boost effects of immunotherapy

New imaging technology could help find tiny tumors

Scientists identify how cells make choice between various mechanisms to repair DNA

Porvair Sciences to improve the diagnosis and treatment of ovarian cancer

Miniature tumor organoids could help guide treatment decisions for people with rare cancers

'Chromosome scanner' that protects against cancer identified

New analysis highlights increasing focus of early-stage clinical trials on rare cancers

Breast cancer study: Family-history-based models perform better than non-family-history based models

Pharmaceutical Manufacturing - Industry Focus eBook eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Pharmaceutical Manufacturing - Industry Focus eBook eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in